Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/d32e8a62-0e64-42b3-be06-2c522c6c4f41/

UHS

Universal Health Services Inc
Chart
$145.17
Latest Week 2026-06-05
HealthcareMedical Care FacilitiesMID
Snapshot 2026-06-07 · 0.0w · Fresh
0.89
OS Score
96.0%
Value
89.0%
Quality
14.0%
Momentum
#94.00000000
TV Rank
7/9
F-Score
0.924
QV
StrategiesValueQualityMomentumCompositeInteractionsFactor AnalysisTrendsFundamentals
Strategy Eligibility
9 of 23 passing
★
OS Composite
OS 0.890
↗
Trending Value
✗
◆
Quality × Value
QV 0.924
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
P/S 0.5
💎
Deep Value
P/E 5.9
◇
VC2 Cheapest
VC2 5.00000000
📐
EBITDA/EV
20.5%
◐
Veiled Value
✗
▣
Piotroski Bargains
F7
🔬
Quality Compounders
✗
📈
Consistent Earners
Noneyr
🌱
GARP
Rev +10%
🔄
Shareholder Yield
✗
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
✗
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
96.0%ile
P/E
5.9×
P/S
0.5×
P/B
1.2×
E/P
0.1698
FCF Yield
0.214
EBITDA/EV
0.205
SH Yield
0.006
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
4.00000000
/100 — 1=cheapest
VC2 (Trending Value)
5.00000000
/100
VC3 (Buyback)
5.00000000
/100
P/E of 5.9x places this firmly in deep value territory. FCF yield of 21.4% is strong — the business generates significant free cash relative to price. VC2 score of 5.00000000/100 puts this in the cheapest decile of the universe — prime Trending Value territory.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
89.0%ile
ROE
0.202
ROA
0.097
Net Margin
0.086
Op Margin
0.122
GPA
0.808
D/E
1.08
Current
1.08
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.104
Earn Growth
0.271
Stability
0.166
lower=better
Accruals
-0.025
lower=better
5yr Consist
Yes
ROE of 20% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
14.0%ile
6M Return
-37.1%
12M Return
-23.1%
12-1 Mom
-10.0%
Risk-Adj
-0.31
Vol 252d
32.5%
Vol 60d
71.2%
↑ Expanding
Max DD 12M
-40.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (71%) is expanding vs long-term (33%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.89
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare · 500 peers
Sector Value %ile
99.0%
Sector Quality %ile
90.6%
P/E z-score
-0.35
P/B z-score
-0.32
Sector Avg OS
63.2%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
IRWD Ironwood Pharmaceuticals Inc 99.0% 93.0% 86.0% 98.0%
RIGL Rigel Pharmaceuticals Inc 98.0% 94.0% 92.0% 76.0%
FBIO Fortress Biotech Inc 98.0% 97.0% 93.0% 74.0%
FBIOP Fortress Biotech Inc Pref Series A 97.0% 81.0% 95.0% 90.0%
WW WW International, Inc. Common Stock 97.0% 88.0% 80.0% 99.0%
PBYI Puma Biotechnology Inc 97.0% 80.0% 97.0% 92.0%
CGEN Compugen 97.0% 90.0% 95.0% 76.0%
MD Mednax Inc 96.0% 87.0% 80.0% 87.0%
Factor Interactions
Value + Quality Intersection
Top-tier on both cheapness (96th) and quality (89th) — the O'Shaughnessy sweet spot, historically the strongest long-term combination.
Falling Knife
Weak momentum (14th) despite looking cheap (96th value). Wait for momentum to stabilise.
Volatility Expanding
60-day vol (71%) significantly exceeds 252-day (33%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
A
86.4% avg (7 factors)
Quality
C
58.3% avg (8 factors)
Momentum
F
11.2% avg (4 factors)
Risk
B
62.5% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.890—1—
Value %ile0.960—1—
Quality %ile0.890—1—
Momentum %ile0.140—1—
F-Score7.000—1—
Confidence1.000—1—
Volatility0.325—0—
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
5.89
Earnings Yield (E/P)
0.1698
Price / Sales
0.50
Price / Book
1.19
Price / Cash Flow
4.70
FCF Yield
21.4%
EBITDA / EV
20.5%
Sales Yield (1/P·S)
1.3039
Shareholder Yield
Div + net buyback / mktcap
0.6%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
20.2%
Return on Assets
9.7%
Net Margin
8.6%
Operating Margin
12.2%
Gross Profit / Assets
Novy-Marx GPA
80.8%
Debt / Equity
1.08
Current Ratio
1.08
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.025
MomentumPrice trend strength over different horizons
6M Return
-37.1%
12M Return
-23.1%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-10.0%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-0.31
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
10.4%
Earnings Growth (YoY)
27.1%
Earnings Stability (CV)
Lower = more stable
0.166
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
7
Dividend Yield
0.6%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
4
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
5
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
5
Trending Value Rank
1=best. Top VC2 decile by 6M momentum
94
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity